Recent
price
P/E
ratio
div
yld
0.72%
ROIC.AI
Analysts Have Conflicting Sentiments on These Healthcare Companies: Praxis Precision Medicines (PRAX), Iovance Biotherapeutics (IOVA) and Evolent Health (EVH)
Evolent Health First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Evolent Health, Inc. (NYSE:EVH) Q1 2024 Earnings Call Transcript
Evolent Health Inc (EVH) Surpasses Revenue Estimates Despite Net Loss in Q1 2024
Evolent Health Inc (EVH) Surpasses Revenue Estimates Despite Net Loss in Q1 2024
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (SGMO), Xencor (XNCR) and Evolent Health (EVH)
Evolent Health (EVH) Q1 2024 Earnings Call Transcript
Evolent Health (EVH) Q1 Earnings and Revenues Top Estimates
Evolent Health (EVH) Q1 Earnings and Revenues Top Estimates
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.
Evolent Announces First Quarter 2024 Results
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 years
Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 years
Does Evolent Health (EVH) Have the Potential to Rally 34.46% as Wall Street Analysts Expect?
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.